Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-006730

Options or other derivatives

  • Director acquired 11,365 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
STARR CHRISTOPHER M Director 2025-03-04 Grant or award · Stock Options +11,365 11,365 D
Loading xslF345X05/rdgdoc.xml…